A biodegradable multiblock co-polymer derived from an α,ω-bis(methylamino)peptide and an α,ω-bis(oxiranylmethyl)poly(ethylene glycol)

Journal of Controlled Release

Volumn 67, Issue 2-3, 2000, Pages 129-139

  Matthews, Susan E ^a   Pouton, Colin W ^a   Threadgill, Michael D ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Biodegradable; Cathepsin B; GlyPheLeuGly; Polyethylene glycol; Retro inverso peptide

Indexed keywords

CATHEPSIN B; COPOLYMER; MACROGOL DERIVATIVE; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BIODEGRADATION; DRUG SYNTHESIS; IN VITRO STUDY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL;

CATHEPSIN B; DRUG DELIVERY SYSTEMS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 0034601099     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00203-0     Document Type: Article

References (25)

1. Matthews S.E., Pouton C.W., Threadgill M.D. Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv. Drug Del. Rev. 18:1996;219-267.
2. Kopeček J., Rejmanová P., Duncan R., Lloyd J.B. Controlled release of drug model from N-(2-hydroxypropyl)methacrylamide copolymers. Ann. NY Acad. Sci. 446:1985;93-104.
3. Seymour L. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;135-187.
4. Vasey P.A., Duncan R., Kaye S.B., Cassidy J. Clinical phase I trial of PK1 (HPMA co-polymer doxorubicin). Eur. J. Cancer. 31A:1995;S929.
5. Kopeček J. The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery. J. Control. Release. 11:1990;279-290.
6. Seymour L.W., Ulbrich K., Steyger P.S., Brereton M., Šubr V., Strohalm J., Duncan R. Tumour tropism and anticancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma. Br. J. Cancer. 70:1994;636-641.
7. Jenkins T.C., Naylor M.A., O'Neill P., Threadgill M.D., Cole S., Stratford I.J., Adams G.E., Fielden E.M., Suto M.J., Steir M.J. Synthesis and evaluation of 1-[3-(2-haloethylamino)propyl]-2-nitroimidazoles as pro-drugs of RSU 1069 and its analogues which are radiosensitizers and bioreductively-activated cytotoxins. J. Med. Chem. 33:1990;2603-2610.
8. Naylor M.A., Threadgill M.D., Webb P., Stratford I.J., Stephens M.A., Fielden E.M., Adams G.E. 2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives. J. Med. Chem. 35:1992;3573-3578.
9. 11B magnetic resonance spectroscopy. Int. J. Radiat. Biol. 70:1996;587-592.
10. Matthews S.E., Pouton C.W., Threadgill M.D. Monofunctional electrophilic and nucleophilic derivatives of meso-tetraphenylporphyrin for attachment to peptides. J. Chem. Soc. Chem. Commun. 1995;1809-1811.
11. Katre N.V. The conjugation of proteins with polyethylene glycol and other polymers-altering properties of proteins to enhance their therapeutic potential. Adv. Drug Del. Rev. 10:1993;91-114.
12. Pechar M., Strohalm J., Ulbrich K., Schacht E. Biodegradable drug carriers based on poly(ethylene glycol) block copolymers. Macromol. Chem. Phys. 198:1997;1009-1020.
13. Ben-Ishai D., Katchalski E. Synthesis of N-carboxy-α-amino acid anhydrides from N-carboxy-α-amino acids by the use of phosphorus tribromide. J. Am. Chem. Soc. 74:1952;3688-3690.
14. Pless J., Boissonnas R.A. Über die Geschwindigkeit der Aminolyse von verschiedenen neuen, aktivierten, N-geschützen α-Aminosäure-phenylestern, insbesondere 2,4,5-Trichlorphenylestern. Helv. Chim. Acta. 46:1963;1609-1625.
15. Kisfaludy L., Löw M., Nyéki O., Szirtes T., Schön I. Die Verwendung von Pentafluorphenylestern bei Peptidsynthesen. Liebigs Ann. Chem. 1973;1421-1429.
16. Lowndes G.J. Ph.D. Thesis. 1994;University of Bath.
17. Maeda H., Kikui T., Nakatsuji Y., Okahara M. Synthesis of bis(aminomethyl)crown ethers. Synthesis. 1983;185-187.
18. Gu X.-P., Ikeda I., Okahara M. Synthesis of glycol diglycidyl ethers using phase-transfer catalysis. Synthesis. 1985;649-651.
19. Feng M., Lu X., Chen Y. Synthesis of monoglycidyl ethers in the presence of polyethylene glycol as phase transfer catalyst. Huaxue Shiji. 12:1990;135-138. (Chem. Abs. 114 (1991) 42408s).
20. Zupancic B.G., Kokalj M. Catalytic activity of polyethylene glycols in the reduction of carbonyl compounds under phase-transfer catalysed conditions. Synth. Commun. 12:1982;881-886.
21. Kopeček J. Benoit H., Rempp P. IUPAC Macromolecules. 1982;305-320 Pergamon, Oxford.
22. Duncan R., Cable H.C., Lloyd J.B., Rejmanová P., Kopeček J. Polymers containing enzymatically degradable bonds. 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] co-polymers to promote efficient degradation by lysosomal enzymes. Makromol. Chem. 184:1983;1997-2008.
23. Rejmanová P., Kopeček J., Pohl J., Baudys M., Kostka V. Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide co-polymers by bovine spleen cathepsin B. Makromol. Chem. 184:1983;2009-2020.
24. Šubr V., Strohalm J., Hirano T., Ito Y., Ulbrich K. Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of methotrexate - Synthesis and in vitro drug release. J. Control. Release. 49:1997;123-132.
25. Matthews S.E., Pouton C.W., Threadgill M.D. Synthesis of porphyrin α,ω-bis(methylamino)peptide constructs. New J. Chem. 23:1999;1087-1096.